United States International Trade Commision Rulings And Harmonized Tariff Schedule
faqs.org  Rulings By Number  Rulings By Category  Tariff Numbers
faqs.org > Rulings and Tariffs Home > Rulings By Number > 2007 NY Rulings > NY N006912 - NY N007027 > NY N006949

Previous Ruling Next Ruling
NY N006949




March 9, 2007

CLA-2-30:RR:E:NC:2:238

CATEGORY: CLASSIFICATION

TARIFF NO.: 3004.90.9140

Mr. Colm Moynihan
NorthStar Healthcare Limited
3300 Cork Airport Business Park
Cork, Ireland

RE: The tariff classification of Carbidopa/Levodopa Tablets and Methocarbamol Tablets from India

Dear Mr. Moynihan:

In your letter dated February 13, 2007, you requested a tariff classification ruling.

The first product, Carbidopa/Levodopa Tablets, is a medicinal preparation, in tablet form, containing Carbidopa (CAS-28860-95-9 (anhydrous)) and Levodopa (CAS-59-92-7) as active ingredients. Carbidopa/Levodopa Tablets are indicated for the treatment of Parkinson’s disease.

The second product, Methocarbamol Tablets, is a medicinal preparation, in tablet form, containing Methocarbamol (CAS-532-03-6), a skeletal muscle relaxant, as the active ingredient. Methocarbamol Tablets are used in the treatment of muscle spasm.

The applicable subheading for both products will be 3004.90.9140, which provides for “Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Other.” The rate of duty will be free.

Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/.

These products may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov.

In your letter, you also requested a ruling on Enalapril Maleate Tablets and Benazepril Hydrochloride Tablets. We note that this office, in NY Ruling Letter N006197, issued to you on February 22, 2007, ruled on the tariff classification of Enalapril Maleate Tablets. We also note that this office, in NY Ruling Letter N006196, also issued to you on February 22, 2007, ruled on the tariff classification of Benazepril Tablets.

This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 CFR 177).

A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033.

Sincerely,

Robert B. Swierupski

Previous Ruling Next Ruling

See also: